Mpox Outbreak Once Again Highlights Vaccine Inequality

Mpox Outbreak Once Again Highlights Vaccine Inequality
An elderly patient receives a dose of a COVID-19 vaccine at a clinic at Orange Farm, near Johannesburg, South Africa, June 3, 2021 (AP photo by Denis Farrell).

Two weeks after the WHO declared the spread of mpox, formerly called monkeypox, in a number of countries in Africa to be a global health emergency, Nigeria has received 10,000 doses of the mpox vaccine donated by the United States. However, the Democratic Republic of Congo, the epicenter of the current outbreak, has yet to receive any vaccine doses. (Reuters)

Our Take

The WHO’s declaration two weeks ago has brought newfound attention to vaccine inequalities around the world. Two years ago, when an outbreak of mpox began to affect Western countries, those governments moved quickly to stop the spread of the disease within their own borders with effective vaccine distribution programs. They were able to do so because many Western countries have large stockpiles of the vaccine available.

No such stockpiles exist in Africa, largely because the pricey vaccines are out of reach for low-income countries. Meanwhile, the international aid agencies that would normally purchase and supply the shots for these countries need WHO approval to do so, which they still don’t have, although the WHO did say the organizations could start talks with vaccine makers while it works on emergency approval.

Keep reading for free!

Get instant access to the rest of this article by submitting your email address below. You'll also get access to three articles of your choice each month and our free newsletter:

Or, Subscribe now to get full access.

Already a subscriber? Log in here .

What you’ll get with an All-Access subscription to World Politics Review:

A WPR subscription is like no other resource — it’s like having a personal curator and expert analyst of global affairs news. Subscribe now, and you’ll get:

  • Immediate and instant access to the full searchable library of tens of thousands of articles.
  • Daily articles with original analysis, written by leading topic experts, delivered to you every weekday.
  • Regular in-depth articles with deep dives into important issues and countries.
  • The Daily Review email, with our take on the day’s most important news, the latest WPR analysis, what’s on our radar, and more.
  • The Weekly Review email, with quick summaries of the week’s most important coverage, and what’s to come.
  • Completely ad-free reading.

And all of this is available to you when you subscribe today.